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The perception of pain involves the activation of the spinal pathway as well as the supra-spinal pathway, which targets brain 
regions involved in affective and cognitive processes. Pain and emotions have the capacity to influence each other reciprocally; 
negative emotions, such as depression and anxiety, increase the risk for chronic pain, which may lead to anxiety and depres-
sion. The amygdala is a key-player in the expression of emotions, receives direct nociceptive information from the parabrachial 
nucleus, and is densely innervated by noradrenergic brain centers. In recent years, the amygdala has attracted increasing inter-
est for its role in pain perception and modulation. In this review, we will give a short overview of structures involved in the 
pain pathway, zoom in to afferent and efferent connections to and from the amygdala, with emphasis on the direct parabra-
chio-amygdaloid pathway and discuss the evidence for amygdala’s role in pain processing and modulation. In addition to the 
involvement of the amygdala in negative emotions during the perception of pain, this brain structure is also a target site for 
many neuromodulators to regulate the perception of pain. We will end this article with a short review on the effects of nora-
drenaline and its role in hypoalgesia and analgesia. 
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Pain is a conscious and subjective experience that is evoked 
in response to a stimulus that causes, or has the potential to 
cause harm. Different aspects constitute the overall experi-
ence of pain; this includes the sensory aspect and the emo-
tional response. Emotions have been proposed to involve 
two motivational systems: the appetitive system evoked by 
pleasant stimuli, such as feeding and sex, and the aversive 
system activated by unpleasant stimuli leading to anxiety 
and withdrawal or aggression and defensive behavior [1,2]. 
Pain and negative emotions seem to be able to influence 
each other reciprocally [2]. Thus, for instance, it has been 
found that the risk of developing chronic musculoskeletal 
pain was two-fold in people suffering from depression 
compared to healthy controls [3] and the severity of depres-
sive symptoms in patients indicated the likelihood to de-
velop neck and back pain [2,4]. In contrast, individuals suf-
fering from chronic pain, such as musculoskeletal pain and 
daily headaches often suffer from depression and show at-
tention deficits [5]. As an underlying mechanism, it has 
been suggested that evoking the aversive system by induc-
ing negative emotions (e.g., with aversive pictures), primes 
this pathway and increases the response of defensive re-
flexes and the perception of pain. Even though data suggests 
that pain is enhanced in combination with the activation of 
aversive feelings, this seems especially to be the case for 
low threshold, anxiety-inducing aversive stimuli [2,6]. In 
contrast, stress-induced analgesia is a phenomenon in which 
fearful and often life-threatening situations (e.g., visual 
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re-exposure of war veterans with posttraumatic stress dis-
order to war, exposure of mice to natural predators) sup-
presses the perception of pain, which may serve the purpose 
of fast defensive action, attention and/or flight from the 
dangerous situation [79]. Stressful situations increase the 
level of noradrenaline in the body [10,11], which acts be-
sides many other neuromodulators, as an important modu-
lator in the perception of pain at the spinal [12,13] and su-
pra-spinal level [14,15].  
Chronic pain is still difficult to treat, and is the cause of 
suffering for many people. Even though the currently 
available research gives us insight in the processing and 
modulation of pain, much work still remains to be done to 
complete the picture of this process. The amygdala is in-
volved in the assessment of emotional aspects and the mod-
ulation of autonomic responses (shallow breathing, sweat-
ing, increases in blood pressure and heart rate) in relation to 
pain. In fearful situations, the amygdala seems to be in-
volved in stress-induced analgesia, which is in part modu-
lated by noradrenaline. Modulation of these negative emo-
tions is one component of therapy for pain. Importantly the 
amygdala, is also involved in assessment of positive emo-
tions, and activation of the appetitive system, that are asso-
ciated with positive emotions, reduces defensive reflexes 
[1,2], and more recent approaches in the treatment of pain 
include cognitive behavioural therapy and relaxation with 
meditation or music to reduce pain [1618]. In summary, 
pain is a multifaceted experience that has an impact on 
many aspects of emotional life. As the amygdala is a central 
component in the neural circuitry that processes emotion, 
understanding the role of the amygdala in anti-nociception 
will have a clear impact on the development of procedures 
to improve treatment options in chronic pain. In this paper, 
we summarize the current state of knowledge about noci-
ception and the amygdala.  
1  Structures involved in the pain pathway 
The detection of mechanical, chemical and thermal noxious 
stimuli occurs through the stimulation of pain receptors 
(nociceptors), located at the terminals of Aδ and C fibers. 
These primary afferent fibers carry nociceptive information 
from the periphery to the dorsal horn of the spinal cord, 
which in turn projects to a wide range of supraspinal struc-
tures, accounting for the multiple dimensions of the pain 
experience [19].  
First, projection neurons from the dorsal horn target a 
number of regions that are involved in the autonomic re-
sponse to pain [2022], such as the periaqueductal grey 
(PAG), dorsal and ventral medulla, hypothalamus [23] and 
nucleus of the solitary tract (NTS) [24]. Most of the struc-
tures targeted by the dorsal horn are also involved in the 
modulation of pain, either through direct or indirect projec-
tions back to the dorsal horn [20]. 
The dorsal horn also sends strong projections to the 
thalamus, which may relay nociceptive information to the 
cortex responsible for sensory discrimination and motiva-
tional responses [19,25,26] and the amygdala, which is in-
volved in the expression of emotions [27,28]. 
Finally, the parabrachial nucleus in particular receives 
some of the largest projections from the dorsal horn and in 
turn projects to PAG, hypothalamus, amygdala as well as 
back to the dorsal horn, thus potentially playing an im-
portant role in both the autonomic and emotional responses 
to pain [21] and have been found to be involved in the de-
scending inhibition of nociception via the reciprocal con-
nections to the dorsal horn [8,29]. These nociceptive inputs 
are summarized in Figure 1. 
2  Amygdala’s connections with other brain  
areas involved in pain processing 
The amygdala is located in the mid temporal lobe and is 
comprised of a number of interconnected nuclei. Of these, 
the basolateral amygdala (BLA), which in simplified mod-
els is often described as the input station, receives inputs 
from all sensory systems [30,31] and the thalamus [32,33]. 
In contrast, the central amygdala (CeA) is considered to be 
the major output station, projecting to the hypothalamus, 
bed nucleus of the stria terminalis and the brainstem [34,35]. 
These downstream connections of the CeA are involved in 
eliciting autonomic and endocrine responses to affective 
stimuli [35,36]. 
2.1  Afferents involved in the pain pathway 
Two distinct pathways are involved in communicating no-
ciceptive information to the amygdala. First, the spino-  
thalamic tract sends nociceptive information from the spinal 
cord to thalamus and hypothalamus. This processed, poly-
modal information then reaches the lateral amygdala, either 
directly or indirectly via the granular and dysgranular insu-
lar cortex, or the anterior cingulate cortex [37,38]. In addi-
tion to this, nociceptive information arrives at the amygdala 
via the spinopontoamygdaloid tract. This pathway sends 
purely nociceptive information from the spinal cord to the 
pontine parabrachial nucleus (pPB), and from there, directly 
to the CeA, which has been defined as the nociceptive 
amygdala. Notably, this pathway is bypassing thalamus and 
lateral amygdala [21,39]. 
2.2  Spinopontoamygdaloid pathway 
The lateral part of the pPB receives nociceptive information 
from where it is conveyed to other brain areas including the 
extended amygdala [40,41]. The pPB is divided into a 
number of subregions that project to different parts of the 
amygdala. Thus, anterograde tracer injections show axon 
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Figure 1  From nociception to emotion: pain circuits involved in direct or indirect projections to the amygdala. Nociceptors are activated by noxious stimuli. 
The signal is carried along Aδ- and C-Fibers, which are relayed in the dorsal horn (DH). This nociceptive information reaches the amygdala via the 
spino-thalamic tract (green) or spinopontoamygdaloid tract (blue). The spino-thalamic tract activates the nucleus of the solitary tract (NST), periacqueductal 
gray (PAG), hypothalamus (HYP) and thalamus (THAL). The hypothalamus and thalamus will then convey processed nociceptive information directly (red) 
or indirectly (black) via the activation of the anterior cingulate cortex (ACC) or insular cortex (INS) to the amygdala (AMYG). The spinopontoamygdaloid 
tract innervates the parabrachial nucleus (PB), which in turn projects to the amygdala. The red dashed boxes show the location of the amygdala in the brain 
(top) and the amygdala magnified (bottom) with the major nuclei basolateral amygdala (BLA) (lateral amygdala (LA), basal amygdala (BA)) and central 
amygdala (CeA) (central capsular amygdala (CeC), central lateral amygdala (CeL), central medial amygdala (CeM)). Nociceptive information from the ACC, 
THAL and HYP reaches the amygdala via the BLA, whereas nociceptive inputs from the PB, HYP and INS target the CeA. 
terminals in the central capsular amygdala (CeC) and cen-
tral medial amygdala (CeM), whereas only moderate inner-
vation is seen in the basolateral amygdala [42,43]. In con-
trast, tracer injections in the lateral region of the pPB result 
in terminal labeling not only in the CeC, but also in the cen-
tral lateral amygdala (CeL) [40,43,44]. Inputs from the pPB 
to the CeA form two distinct types of terminals that have 
been described as bushy or perisomatic. The bushy type has 
highly branched terminals with many boutons, can be found 
throughout all subnuclei of the CeA, and appear to be typi-
cal asymmetric glutamatergic synaptic terminals. In contrast, 
the perisomatic type forms basket-like terminals around 
somata of neurons, particularly in the CeL part and occa-
sionally in the CeC [43]. The terminals of this large projec-
tion from the parabrachial to the central amygdala are 
shown in Figure 2. 
The functional role of lateral pPB to CeA connections, 
and their involvement in processing pain has been investi-
gated using electrophysiological recordings in vitro and in 
vivo as well as fMRI imaging. Initially, electrophysiological 
recordings in vivo found that the majority (70%) of pPB 
neurons projecting to the CeA, identified by antidromic 
stimulation, responded to either noxious mechanical and/or 
thermal stimulation [39] as well as to noxious visceral stim-
uli [45]. Most neurons had large receptive fields and were 
able to respond to stimulation of several parts of the body 
[39]. Moreover, in vivo single-unit recordings showed that 
the majority of CeA neurons also responded to noxious su-
perficial (skin) and deep body (joint) mechanical and/or 
thermal stimuli [46,47] of a wide range of body parts. Most 
of these nociceptive neurons could be divided into two dis-
tinct populations: one group was excited (46%) and prefer-
entially located in the CeC, whereas the other group was 
inhibited (34%) by noxious stimulation and mainly located 
in the center of the CeL [45]. In confirmation of these re-
sults, fMRI studies in humans have shown besides other 
brain areas, the activation of the amygdala in response to 
noxious stimulation [48].  
2.3  Efferents involved in the pain pathway 
Direct projections from the nociceptive amygdala, labeled 
by using targeted CeC and CeL anterograde tracer injections, 
have been found to the cholinergic basal nuclei, such as the 
substantia innominata, the hypothalamus which controls 
autonomic functions such as heart rate and blood pressure,  
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Figure 2  Labeled parabrachial nucleus projections in the central amyg-
dala from a coronal section of mouse brain. Basal amygdala (BA), lateral 
amygdala (LA), capsular (CeC) and lateral (CeL ) and medial (CeM) divi-
sions of the central amygdala nuclei are outlined in black dashed lines and 
medial, lateral, dorsal and ventral have been indicated for orientation. The 
white-boxed region in the CeL corresponds to the higher magnification 
inset image. Labeled putative synapses surrounding the cell bodies of neu-
rons in the central amygdala exhibited either a bushy type morphology 
which are highly branched with multiple buttons (arrowhead) or larger 
perisomatic type (arrows), which were only identified in the CeC and CeL 
divisions. Adult C57BL6 (n=6, <P35) were deeply anaesthetized with an 
intra-peritoneal injection of ketamine (10%) and xylazine (5%) in saline at 
100 µL per 10 g. Animals were placed into a stereotactic apparatus and 
heads secured with ear bars and a mouthpiece. Body temperature was 
maintained using a heating pad set at 35°C. The skull was exposed using a 
scalpel blade and Bregma determined. Holes were drilled through the skull 
at the coordinates (Bregma 0.52, medial/lateral +/ 0.15 and dorsal/  
ventral 0.26) established from the mouse brain atlas. Glass electrodes 
with a long tapered shaft and a 30–50 µm diameter hole were filled with 
0.25 µL of the biotinylated dextrans tracer (5% BDA, 10000 MW, molecu-
lar probes) and stereotatically injected bilaterally into the parabrachial 
nucleus. Animals were then removed from the stereotactic stage and the ski 
over the incision site sealed using Vetbond. Animals were injected subcu-
taneously with enrofloxacin (1 µL per 10 g), a fluoroquinolone antibiotic, 
and torbugesic (2.5 µL per 10 g), a centrally acting analgesic, both made up 
to 0.5 mL in saline. Animals were allowed to recover for 7 d. Animals 
were anaesthetized with an over dose of sodium pentobarbital (Lethabarb, 
100 mg kg1 intraperitoneal) and perfusion fixed transcardially with saline 
(0.9% NaCl) followed by 4% paraformaldehyde, 0.5% glutaraldehyde in 
0.1 mol L1 phosphate buffer. Brains were removed and immersion fixed in 
the same fixative for 3 h and then washed in phosphate buffered saline (0.1 
mol L1 PBS). 50 µm thick sections were cut using a vibratome (Lecia 
1000s) and labeled with streptavidin horseradish peroxidase for 16 h at 
room temperature. Labeling was revealed using 3,3′-Diaminobenzidine 
(DAB) as a chromagen. Sections were mounted onto glass slides, visual-
ized and imaged using Axio Imager Z1 microscope with a Zeiss AxioCam 
HRc digital camera. This work was approved by the University of Queens-
land Animal Ethics Committee and experiments were carried out in ac-
cordance with National Health and Medical Research Council of Australia 
guidelines. Adequate measures were taken to minimize pain or discomfort 
to animals. 
and the bed nucleus of the stria terminalis, which can influ-
ence the autonomic system [49,50]. However, most tracer 
studies did not distinguish between subnuclei in the CeA, 
and include the CeM. Projections from the CeA have also 
been found in the PAG, the parabrachial nucleus and the 
nucleus of the solitary tract, all of which are involved in 
descending control of nociception [5154]. Finally, the CeA 
also influences the forebrain via indirect projections with 
projections to cortical areas (orbital and medial prefrontal 
cortices, agranular insular cortex) involved in cognitive pro-
cesses such as attention, consciousness, discrimination of 
pain signals and decision making, and the dorsal thalamus, 
which processes information from sensory systems [55]. 
3  The amygdala and the modulation of per-
ceived pain 
It has long been appreciated that persistent pain can be 
modified by emotional and psychosocial factors. The 
amygdala is ideally situated to play a key role in the emo-
tional modulation of pain due to its afferent and efferent 
projections to and from brain areas involved in nociception 
and autonomic responses, important for the expression of 
emotions such as fear. Indeed, the amygdala appears to be 
involved in the enhancement (hyperalgesia), as well as in 
the reduction or inhibition (hypoalgesia/analgesia) of pain 
signals. 
Evidence for a role of the amygdala in the enhancement 
or reduction of nociception comes from behavioural exper-
iments. Hyperalgesia to previous electrical tail shocks in 
rats was measured as a reduction in the vocalization thresh-
old. In CeA lesions this effect was abolished, suggesting a 
role in sensitization [56]. In addition, bilateral lesions of the 
amygdala lead to an increase in the pain threshold in rats 
measured as the time of vocalization in response to increas-
ing electrical tail stimulation [57], suggesting a role in the 
expression of pain. In contrast, a role of the amygdala in 
hypoalgesia is suggested by unilateral stimulation of the 
amygdala, which led to a reduction in pain behavior during 
tail flick experiments [58]. In addition, central amygdala 
lesions attenuated stress-induced analgesia to different 
stressors, such as the exposure to predators, electrical foot-
shock and re-exposure to environments associated with 
footshock [8,59].  
3.1  Analgesic and hypoalgesic neuromodulation by 
noradrenaline 
The number of neuromodulators and the diversity of their 
effects on the perception of pain in structures involved in 
nociception is immense and would exceed the scope of this 
review. Here we will concentrate on the hypoalgesic and 
analgesic effects promoted by noradrenaline with the focus 
388 Strobel C, et al.   Sci China Life Sci   April (2014) Vol.57 No.4 
of its action in the amygdala. Earlier studies suggested that 
the analgesic effect of noradrenaline occurs at the level of 
the spinal cord. However, since then there has been cumula-
tive evidence for noradrenergic modulation at supra-spinal 
levels, which involves several brain areas (for review see 
[20]). Noradrenergic receptors can be found in all su-
praspinal structures that are involved in pain processing, 
even though the exact mechanism of action is still not un-
derstood [15]. 
Several findings support the amygdala as a target site for 
noradrenaline involved in pain modulation during height-
ened emotional states. The central amygdala is densely in-
nervated by the noradrenergic system, and receives its main 
adrenergic fibers from the locus coeruleus and a smaller 
noradrenergic input from the ventrolateral medulla [60,61]. 
Noradrenaline levels in the amygdala are increased in re-
sponse to stressful situations as revealed by microdialysis 
[62,63]. In addition, almost all types of adrenergic receptors 
are present in the central amygdala. Evidence for 1-receptor 
activation was revealed in the central amygdala in animal 
pain model with injection of formalin in the mouse hindpaw 
[64]. Immunolabelling has shown 1b-adrenoceptors in the 
basolateral and CeA [65], 2a- [66] and 2c [67] in various 
nuclei including CeL and CeC, whereas 2b-noradrenergic 
receptors do not appear to be present [68]. Weak labeling in 
the amygdala has also been seen for beta-adrenergic recep-
tors [69,70]. As described above, the parabrachial input, 
carrying nociceptive information, forms single-fiber periso- 
matic basket terminals in the CeL that has multiple release 
sites. These glutamatergic synapses have all-or-nothing  
responses with fixed amplitudes, independent of stimulation 
strength, and release of noradrenaline depresses these syn-
apses [71]. Thus, release of noradrenaline effectively re-
duces nociceptive sensory input into the CeA. Interestingly, 
behavioral experiments have shown that intrathecal injec-
tion of 2 adrenergic receptor agonists has analgesic func-
tions [72]. More specifically, microinjection of the 2 ad-
renergic receptor agonist in the CeA decreased the sensitiz-
ing effect of foot shocks on the amplitude of the acoustic 
startle response [73]. Furthermore, microinjection of the 
noradrenergic agonists clonidine in the CeA increased the 
tail-flick latency, again supporting a role for noradrenergic 
receptors in antinociception [74], whereas microinjections 
of an 2 receptor antagonist preceding the induction of 
stress by restraining, blocked the stress-induced hypoalgesia 
as measured as the paw- withdrawal latency [14]. Together, 
these data are consistent with the involvement of the amyg-
dala in stress-induced analgesia and hypoalgesia, triggered 
by stress-induced release of noradrenaline in this region. 
Parabrachial inputs carrying nociceptive information to 
the CeA form large glutamatergic synapses on CeA neurons. 
As with many other glutamatergic synapses, repetitive 
stimulation of these inputs results in long-term potentiation 
(LTP). Synaptic responses are potentiated by an increase in 
presynaptic transmitter release, which involves the activa-
tion of adenylyl cyclase and protein kinase A (PKA) [75]. 
However, the targets of the signaling pathway are unknown. 
Interestingly, noradrenergic neuromodulation and the re-
sulting partial block of transmitter release is also mediated 
presynaptically as a result of the activation of presynaptic 
2-adrenoceptors activated Gi/o-G-protein coupled receptors. 
This in turn, releases G subunits that act on proteins in-
volved in vesicle fusion with no effect on presynaptic cal-
cium channels [71]. Current insights into transmitter release, 
such as proteins involved in vesicle release and recycling 
mainly come from direct presynaptic recordings in the Ca-
lyx of Held [76,77]. In future experiments, the large size of 
parabrachial terminals may allow for similar recordings to 
investigate the mechanisms that are engaged during both 
LTP and noradrenergic modulation of these synapses. 
4  Perspectives 
Studies of the effects of noradrenaline in the amygdala have 
mainly focused on the modulatory role in emotional 
memory [78], and evidence for the involvement in pain 
modulation is relatively sparse. However, over recent years, 
a role for the amygdala in hypoalgesia and analgesia during 
emotionally heightened states such as fear has become of 
more interest. Much evidence has implicated release of 
noradrenaline, and activation of the α2 receptors in the cen-
tral amygdala in stress-induced analgesia [14]. The para-
brachial afferents form large perisomatic excitatory synap-
ses in the central amygdala, and carry nociceptive infor-
mation into the nociceptive amygdala [43] are key targets 
for modulation by noradrenaline [71]. Efferent fibers from 
the CeA project to areas in the brain stem, such as PAG, 
medulla and pPB, which are involved in descending noci-
ceptive inhibition and are likely to be influenced by amyg-
dala’s output. Understanding noradrenalin’s hypoalgesic 
actions at this central relay synapse between pain and 
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